Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01748175 · ClinicalTrials.gov registry record
Implications and Stability of Clinical and Molecular Phenotypes of Severe Asthma
A clinical trial, sponsored by Sally E. Wenzel MD.
- Completed
- Registry status
- 715
- Enrollment target
NCT01748175: Completed study, sponsored by Sally E. Wenzel MD.
NCT01748175 is a clinical trial that has completed, run by Sally E. Wenzel MD. The registered enrollment target is 715 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01748175 has completed, sponsored by Sally E. Wenzel MD.
- COMPLETED
- Registry status
- 715 participants
- Enrollment target
Study Summary
The Severe Asthma Research Program III is an NIH cooperative agreement involving 7 clinical centers that encompass a multidisciplinary partnerships between asthma clinician-scientists and scientists with expertise in immunology, pulmonary physiology, molecular genetics, molecular phenotyping, imaging, and bioinformatics. These clinical centers will jointly recruit volunteers with asthma for an observational longitudinal follow-up study. However, centers will also conduct specific mechanistic research projects at each participating institution. The University of Pittsburgh's SARP III study will determine the molecular and clinical stability of asthma phenotypes over time.
Primary Outcome
Determine the impact of mast cell markers on human airway epithelial cell phenotype and function.
Interventions
- DRUG Triamcinolone Acetonide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 715 participants |
| Start Date | 2013-01 |
| Est. Completion | 2022-01 |
What the finished NCT01748175 record still lists
NCT01748175 is an observational study that tracks outcomes without assigning an intervention. The registered 715 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Triamcinolone Acetonide is the first listed.
NCT01748175 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01748175 about?
NCT01748175 is a clinical study titled "Implications and Stability of Clinical and Molecular Phenotypes of Severe Asthma". The Severe Asthma Research Program III is an NIH cooperative agreement involving 7 clinical centers that encompass a multidisciplinary partnerships between asthma clinician-scientists and scientists with expertise in immunology, pulmonary physiology, molecular genetics, molecular phenotyping, imagin...
What is the current status of trial NCT01748175?
This trial is currently completed. The enrollment target is 715 participants. The study started on 2013-01. Estimated completion is 2022-01.
What interventions are being tested in trial NCT01748175?
The interventions under investigation include: Triamcinolone Acetonide (DRUG).
Who is sponsoring clinical trial NCT01748175?
This trial is sponsored by Sally E. Wenzel MD, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04680000 · 716 participants · NA
Chronic Pain Management In Primary Care Using Behavioral Health Consultants
- NCT05208762 · 714 participants · Phase 1
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- NCT06758401 · 714 participants · Phase 3
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
- NCT04916327 · 720 participants · NA
Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 1
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia